Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinson's disease: mechanisms and models.

William Dauer1, Serge Przedborski

  • 1Department of Neurology, Columbia University, New York, NY 10032, USA.

Neuron
|September 16, 2003
PubMed
Summary

Parkinson's disease (PD) involves the death of specific brain cells. Understanding protein misfolding and cellular dysfunction is key to developing new therapies that protect these neurons.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Gait and Pose Analysis Utilizing Computer Vision for Parkinsonian Behavioral Phenotyping in Mice.

bioRxiv : the preprint server for biology·2026
Same author

Detection of phosphorylated α-synuclein in skin - Authors' reply.

The Lancet. Neurology·2026
Same author

Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids.

Nature communications·2025
Same author

A wolf in synuclein clothing: Creutzfeldt-Jakob disease disguised as MSA.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2025
Same author

Parkinson's Disease, Second Edition.

Cold Spring Harbor perspectives in medicine·2025
Same author

Rare <i>PANK2</i> variants and pantothenate-kinase-associated neurodegeneration in the Dominican Republic.

Brain communications·2025

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra.
  • Current treatments for PD manage symptoms but do not prevent neuronal degeneration.
  • A deeper understanding of molecular mechanisms driving neurodegeneration is crucial for developing neuroprotective therapies.

Purpose of the Study:

  • To explore the molecular underpinnings of Parkinson's disease pathogenesis.
  • To investigate the role of protein misfolding and ubiquitin-proteasome pathway dysfunction in PD.
  • To evaluate the contribution of mitochondrial dysfunction and oxidative stress to neurodegeneration.

Main Methods:

  • Review of existing literature on PD pathogenesis.
  • Analysis of findings from neurotoxin-based models (e.g., MPTP).
  • Consideration of insights from genetic models of PD.

Main Results:

  • Protein misfolding and impaired ubiquitin-proteasome system function are hypothesized to be central to PD.
  • Mitochondrial dysfunction and oxidative stress may exacerbate PD by promoting protein aggregation.
  • Neurotoxin and genetic models have been instrumental in understanding neuronal cell death pathways.

Conclusions:

  • Elucidating the molecular cascade of dopaminergic neuron death is essential for therapeutic development.
  • PD gene-based models offer a promising avenue for understanding selective neuronal vulnerability in the substantia nigra.
  • Targeting protein misfolding and related cellular pathways may offer neuroprotective strategies for Parkinson's disease.

Related Experiment Videos